MCP Agilent Technologies
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/mcp.R600011-MCP200 on May 29, 2006.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
R600011-MCP200v1
5/10/1772    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bertucci, F.
Right arrow Articles by Goncalves, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertucci, F.
Right arrow Articles by Goncalves, A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 5:1772-1786, 2006.
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc.

Cancer

Proteomics of Breast Cancer

Principles and Potential Clinical Applications*

François Bertucci{ddagger},§,¶,||, Daniel Birnbaum{ddagger} and Anthony Goncalves§,¶,**

From the {ddagger} Centre de Recherche en Cancérologie de Marseille, Département d’Oncologie Moléculaire, Institut Paoli-Calmettes (IPC) and UMR599 INSERM, § Département d’Oncologie Médicale and ** Département de Pharmacologie Moléculaire, IPC, and Faculté de Médecine, Université de la Méditerranée, 13009 Marseille, France

Progresses in screening, early diagnosis, prediction of aggressiveness and of therapeutic response or toxicity, and identification of new targets for therapeutic will improve survival of breast cancer. These progresses will likely be accelerated by the new proteomic techniques. In this review, we describe the different techniques currently applied to clinical samples of breast cancer and the most important results obtained with the two most popular proteomic approaches in translational research (tissue microarrays and SELDI-TOF).

|| To whom correspondence should be addressed: Dépt. d’Oncologie Moléculaire, Inst. Paoli-Calmettes, 232 Bd. Sainte-Marguerite, 13009 Marseille, France. Tel.: 33-4-91-22-35-37; Fax: 33-4-91-22-36-70; E-mail: bertuccif{at}marseille.fnclcc.fr


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Cell. ProteomicsHome page
A. Goncalves, E. Charafe-Jauffret, F. Bertucci, S. Audebert, Y. Toiron, B. Esterni, F. Monville, C. Tarpin, J. Jacquemier, G. Houvenaeghel, et al.
Protein Profiling of Human Breast Tumor Cells Identifies Novel Biomarkers Associated with Molecular Subtypes
Mol. Cell. Proteomics, August 1, 2008; 7(8): 1420 - 1433.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.